Status:
WITHDRAWN
Modulating Context Generalization Through Transcranial Direct Current Stimulation
Lead Sponsor:
Butler Hospital
Conditions:
Anxiety and Fear
Eligibility:
All Genders
18-55 years
Phase:
NA
Brief Summary
Behavioral adaptation is particularly relevant to anxiety and related disorders, where exposure-based therapies rely on such adaptation as part of behavior therapy.. However, while initial fear reacti...
Eligibility Criteria
Inclusion
- Primary diagnosis of an anxiety or related disorder, (defined as panic disorder, social anxiety disorder, generalized anxiety disorder, obsessive-compulsive disorder, and/or post-traumatic stress disorder);
- aged 18-55;
- ability to speak, read, write, and understand English sufficiently well to complete study procedures and provide informed consent;
- Stable psychiatric medication use for at least 6 weeks.
Exclusion
- Lifetime history of psychotic symptoms or bipolar disorder,
- Current substance use disorder;
- Acute suicidality or homicidality,
- Significant neurological disorder,
- Any problems that would interfere with study participation, significant or unstable medical disorders and tDCS-related contraindications (e.g., implanted metallic substances, pregnancy, holes in the skull, skin abnormalities under stimulation sites).
Key Trial Info
Start Date :
February 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2019
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03374605
Start Date
February 1 2018
End Date
December 1 2019
Last Update
August 7 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Butler Hospital
Providence, Rhode Island, United States, 02906